• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管腔狭窄是食管鳞状细胞癌的一个独立预后因素。

Esophageal luminal stenosis is an independent prognostic factor in esophageal squamous cell carcinoma.

作者信息

Yang Yu-Shang, Hu Wei-Peng, Ni Peng-Zhi, Wang Wen-Ping, Yuan Yong, Chen Long-Qi

机构信息

Department of Thoracic Surgery, West China Hospital of Sichuan University, No. 37, Guoxue Alley, Chengdu, Sichuan, China.

出版信息

Oncotarget. 2017 Jun 27;8(26):43397-43405. doi: 10.18632/oncotarget.14762.

DOI:10.18632/oncotarget.14762
PMID:28118615
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5522155/
Abstract

BACKGROUND

Predictive value of preoperative endoscopic characteristic of esophageal tumor has not been fully evaluated. The aim of this study is to investigate the impact of esophageal luminal stenosis on survival for patients with resectable esophageal squamous cell carcinoma (ESCC).

METHODS

The clinicopathologic characteristics of 623 ESCC patients who underwent curative resection as the primary treatment between January 2005 and April 2009 were retrospectively reviewed. The esophageal luminal stenosis measured by endoscopy was defined as a uniform measurement preoperatively. The impact of esophageal luminal stenosis on patients' overall survival (OS) and relation with other clinicopathological features were assessed. A Cox regression model was used to identify prognostic factors.

RESULTS

The results showed that OS significantly decreased in patients with manifest stenotic tumor compared with patients without luminal obstruction (P<0.05). Considerable esophageal luminal stenosis was associated with a higher T stage, longer tumor length, and poorer differentiation (all P<0.05). In multivariate survival analysis, esophageal luminal stenosis remained as an independent prognostic factor for OS (P= 0.036).

CONCLUSIONS

Esophageal luminal stenosis could have a significant impact on the OS in patients with resected ESCC and may provide additional prognostic value to the current staging system before any cancer-specific treatment.

摘要

背景

食管肿瘤术前内镜特征的预测价值尚未得到充分评估。本研究旨在探讨食管腔狭窄对可切除食管鳞状细胞癌(ESCC)患者生存的影响。

方法

回顾性分析2005年1月至2009年4月间623例行根治性切除作为主要治疗的ESCC患者的临床病理特征。术前通过内镜测量的食管腔狭窄定义为术前的统一测量值。评估食管腔狭窄对患者总生存(OS)的影响及其与其他临床病理特征的关系。采用Cox回归模型确定预后因素。

结果

结果显示,与无管腔阻塞的患者相比,有明显狭窄肿瘤的患者OS显著降低(P<0.05)。明显的食管腔狭窄与更高的T分期、更长的肿瘤长度和更差的分化相关(均P<0.05)。在多因素生存分析中,食管腔狭窄仍然是OS的独立预后因素(P = 0.036)。

结论

食管腔狭窄可能对切除的ESCC患者的OS有显著影响,并且在任何癌症特异性治疗之前可能为当前分期系统提供额外的预后价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f3d/5522155/430b2ad783ac/oncotarget-08-43397-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f3d/5522155/39ca361b3388/oncotarget-08-43397-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f3d/5522155/fa37cce330df/oncotarget-08-43397-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f3d/5522155/f78011e660ad/oncotarget-08-43397-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f3d/5522155/f8157ad18aab/oncotarget-08-43397-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f3d/5522155/02f2683cdb97/oncotarget-08-43397-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f3d/5522155/430b2ad783ac/oncotarget-08-43397-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f3d/5522155/39ca361b3388/oncotarget-08-43397-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f3d/5522155/fa37cce330df/oncotarget-08-43397-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f3d/5522155/f78011e660ad/oncotarget-08-43397-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f3d/5522155/f8157ad18aab/oncotarget-08-43397-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f3d/5522155/02f2683cdb97/oncotarget-08-43397-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f3d/5522155/430b2ad783ac/oncotarget-08-43397-g006.jpg

相似文献

1
Esophageal luminal stenosis is an independent prognostic factor in esophageal squamous cell carcinoma.食管腔狭窄是食管鳞状细胞癌的一个独立预后因素。
Oncotarget. 2017 Jun 27;8(26):43397-43405. doi: 10.18632/oncotarget.14762.
2
Endoscopic tumor length is an independent prognostic factor in esophageal squamous cell carcinoma.内镜下肿瘤长度是食管鳞癌的独立预后因素。
Ann Surg Oncol. 2012 Jul;19(7):2149-58. doi: 10.1245/s10434-012-2273-y. Epub 2012 Mar 10.
3
Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma.对接受手术切除的食管鳞状细胞癌患者进行第7版TNM分类评估。
World J Gastroenterol. 2014 Dec 28;20(48):18397-403. doi: 10.3748/wjg.v20.i48.18397.
4
The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.神经周围侵犯状态可预测局部晚期食管鳞状细胞癌术后放疗的疗效。
Int J Clin Exp Pathol. 2015 Jun 1;8(6):6881-90. eCollection 2015.
5
Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma.可切除食管鳞状细胞癌患者术前淋巴细胞与单核细胞比值的预后意义
Asian Pac J Cancer Prev. 2015;16(6):2245-50. doi: 10.7314/apjcp.2015.16.6.2245.
6
Prognostic value of pre-operative serum uric acid levels in esophageal squamous cell carcinoma patients who undergo R0 esophagectomy.接受R0食管切除术的食管鳞状细胞癌患者术前血清尿酸水平的预后价值
Cancer Biomark. 2016 Jun 7;17(1):89-96. doi: 10.3233/CBM-160621.
7
Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.中性粒细胞与淋巴细胞比值在可手术切除食管鳞状细胞癌中的预后作用
World J Gastroenterol. 2015 May 14;21(18):5591-7. doi: 10.3748/wjg.v21.i18.5591.
8
Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy.食管鳞状细胞癌患者接受食管切除术后辅助化疗,针对此前未接受过治疗患者的预后列线图。
Jpn J Clin Oncol. 2016 Apr;46(4):336-43. doi: 10.1093/jjco/hyv206. Epub 2016 Jan 26.
9
Prognostic significance of lymph node metastasis in esophageal squamous cell carcinoma.食管鳞状细胞癌中淋巴结转移的预后意义
Pathol Res Pract. 2017 Jul;213(7):842-847. doi: 10.1016/j.prp.2017.01.023. Epub 2017 Feb 3.
10
The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma.术前敏感改良格拉斯哥预后评分在预测食管鳞状细胞癌长期生存方面优于改良格拉斯哥预后评分。
Oncotarget. 2016 Oct 11;7(41):67485-67494. doi: 10.18632/oncotarget.11268.

引用本文的文献

1
Efficacy and Safety of Immune Checkpoint Inhibitor Combination Therapy for Dysphagia in Patients with Advanced Esophageal Cancer.免疫检查点抑制剂联合疗法治疗晚期食管癌吞咽困难的疗效与安全性
J Clin Med. 2024 Aug 15;13(16):4806. doi: 10.3390/jcm13164806.
2
Prognostic factors for esophageal respiratory fistula in unresectable esophageal squamous cell carcinoma treated with radiotherapy.不可切除食管鳞癌放疗后食管呼吸瘘的预后因素。
Sci Rep. 2024 Jul 26;14(1):17144. doi: 10.1038/s41598-024-67859-0.
3
Raltitrexed enhanced antitumor effect of anlotinib in human esophageal squamous carcinoma cells on proliferation, invasiveness, and apoptosis.

本文引用的文献

1
Recurrence risk after Ivor Lewis oesophagectomy for cancer.艾弗·刘易斯食管癌切除术后的复发风险。
J Cardiothorac Surg. 2013 Nov 21;8:215. doi: 10.1186/1749-8090-8-215.
2
Endoscopic tumor length is an independent prognostic factor in esophageal squamous cell carcinoma.内镜下肿瘤长度是食管鳞癌的独立预后因素。
Ann Surg Oncol. 2012 Jul;19(7):2149-58. doi: 10.1245/s10434-012-2273-y. Epub 2012 Mar 10.
3
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.
雷替曲塞增强安罗替尼对人食管鳞癌细胞增殖、侵袭和凋亡的抗肿瘤作用。
BMC Cancer. 2023 Mar 4;23(1):207. doi: 10.1186/s12885-023-10691-y.
4
The Impact of Pretreatment Esophageal Stenosis on Survival of Esophageal Cancer Patients.治疗前食管狭窄对食管癌患者生存的影响。
Ann Surg Oncol. 2023 May;30(5):2703-2712. doi: 10.1245/s10434-022-12945-8. Epub 2022 Dec 26.
5
Predictive value of preoperative weight loss on survival of elderly patients undergoing surgery for esophageal squamous cell carcinoma.术前体重减轻对老年食管鳞状细胞癌手术患者生存的预测价值。
Transl Cancer Res. 2019 Dec;8(8):2752-2758. doi: 10.21037/tcr.2019.10.29.
6
Prognostic impact of tumor length in esophageal Cancer: a systematic review and Meta-analysis.食管癌肿瘤长度的预后影响:系统评价和荟萃分析。
BMC Cancer. 2021 Sep 3;21(1):988. doi: 10.1186/s12885-021-08728-1.
7
Letter to the Editor: Dysphagia Score as a Predictor of Adverse Events Due to Triplet Chemotherapy and Oncological Outcomes in 434 Consecutive Patients with Esophageal Cancer.致编辑的信:吞咽困难评分作为434例连续性食管癌患者三联化疗不良事件及肿瘤学结局的预测指标
Ann Surg Oncol. 2021 Dec;28(Suppl 3):844-845. doi: 10.1245/s10434-021-10308-3. Epub 2021 Jun 15.
8
Raltitrexed Enhances the Antitumor Effect of Apatinib in Human Esophageal Squamous Carcinoma Cells via Akt and Erk Pathways.雷替曲塞通过Akt和Erk通路增强阿帕替尼对人食管鳞状癌细胞的抗肿瘤作用。
Onco Targets Ther. 2020 Dec 1;13:12325-12339. doi: 10.2147/OTT.S276125. eCollection 2020.
9
Clinical Factors to Predict the Response to Concurrent Chemoradiotherapy and Survival in Esophageal Cancer Patients.临床因素预测食管癌患者同步放化疗反应和生存的情况。
Gut Liver. 2020 Jul 15;14(4):450-458. doi: 10.5009/gnl19165.
10
Long-term outcomes of multimodal therapy combining definitive chemoradiotherapy and salvage surgery for T4 esophageal squamous cell carcinoma.多模态治疗(包括根治性放化疗和挽救性手术)治疗 T4 期食管鳞癌的长期疗效。
Int J Clin Oncol. 2020 Apr;25(4):552-560. doi: 10.1007/s10147-019-01590-z. Epub 2019 Dec 11.
可切除食管癌新辅助化疗或放化疗后的生存:更新的荟萃分析。
Lancet Oncol. 2011 Jul;12(7):681-92. doi: 10.1016/S1470-2045(11)70142-5. Epub 2011 Jun 16.
4
Endoscopic esophageal tumor length: a prognostic factor for patients with esophageal cancer.内镜下食管肿瘤长度:食管癌患者的预后因素。
Cancer. 2011 Jan 1;117(1):63-9. doi: 10.1002/cncr.25373. Epub 2010 Aug 27.
5
The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.美国癌症联合委员会:第 7 版 AJCC 癌症分期手册与 TNM 的未来。
Ann Surg Oncol. 2010 Jun;17(6):1471-4. doi: 10.1245/s10434-010-0985-4.
6
Prognostic significance of endoluminal ultrasound-defined disease length and tumor volume (EDTV) for patients with the diagnosis of esophageal cancer.内镜超声定义的疾病长度和肿瘤体积(EDTV)对诊断为食管癌患者的预后意义。
Surg Endosc. 2010 Apr;24(4):870-8. doi: 10.1007/s00464-009-0681-2.
7
Preoperative therapy for esophageal cancer.食管癌的术前治疗。
Gastroenterol Clin North Am. 2009 Mar;38(1):135-52, ix. doi: 10.1016/j.gtc.2009.01.012.
8
Esophageal tumor length is independently associated with long-term survival.食管肿瘤长度与长期生存独立相关。
Cancer. 2009 Feb 1;115(3):508-16. doi: 10.1002/cncr.24062.
9
Total number of resected lymph nodes predicts survival in esophageal cancer.切除淋巴结的总数可预测食管癌患者的生存率。
Ann Surg. 2008 Aug;248(2):221-6. doi: 10.1097/SLA.0b013e31817bbe59.
10
Prognostic significance of failure to cross esophageal tumors by endoluminal ultrasound.腔内超声无法穿过食管肿瘤的预后意义。
Dis Esophagus. 2008;21(6):508-13. doi: 10.1111/j.1442-2050.2008.00809.x. Epub 2008 Apr 22.